Reata Pharmaceuticals Inc (RETA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5320 LEGACY DRIVE PLANO, TX 75024

Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metaboli® and inflammation. Reata's two most advanced clinical candidates, bardoxolone and omaveloxolone, target the important transcription factor Nrf2 that promotes the resolution of inflammation by restoring mitochondrial function, reducing oxidative stress, and inhibiting pro-inflammatory signaling. Bardoxolone and omaveloxolone are investigational drugs, and their safety and efficacy have not been established by any agency.

Data as of 2021-06-19 12:30:57 -0400
Market Cap4.329 Billion Shares Outstanding31.368 Million Avg 30-day Volume480.045 Thousand
P/E Ratio-16.25741 Dividend Yield EPS-7.73
Price/Sales502.77 Debt to Equity2.21 EBITDA-212.742 Million
Price to Book Value11.72 Forward PE-16.16 Enterprise Value3.551 Billion
Total Cash777.624 Million Current Debt114.359 Million Gross Profit8.61 Million
BETA0.9194 52-week High/Low186.82 / 76.34 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from RETA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 9 -55.56% 2 (0.12%) 3 (0.17%) -33.33%
Funds Holding: 198 201 -1.49% 67 (3.93%) 70 (4.06%) -4.29%
13F shares: 25.036 Million 24.668 Million 1.49% 10.949 Million 11.247 Million -2.64%
% Ownership 80.0113 79.3924 0.78% 34.992 36.1964 -3.33%
New Positions: 37 49 -24.49% 16 23 -30.43%
Increased Positions 76 69 10.14% 24 18 33.33%
Closed Positions 39 30 30.0% 19 13 46.15%
Reduced Positions 54 63 -14.29% 18 25 -28.0%
Total Calls 283.945 Thousand 134.301 Thousand 111.42% 183.6 Thousand 57.9 Thousand 217.1%
Total Puts 387.835 Thousand 343.576 Thousand 12.88% 193.42 Thousand 222.471 Thousand -13.06%
PUT/CALL Ratio 1.37 2.56 -46.48% 1.05 3.84 -72.66%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RETA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RETA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

80 Thousand total shares from 17 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MEYER COLIN JOHN CHIEF RESEARCH OFFICER

  • Officer
571,669 2021-06-14 4

NIELSEN JACK

  • Director
6,201 2021-06-10 1

MCGAUGHY R KENT JR

  • Director
  • 10% Owner
5,690 2021-06-10 2

ROSE WILLIAM

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUP
5,810 2021-06-10 1

MCCLELLAN WILLIAM D. JR.

  • Director
5,000 2021-06-10 3

EDWARDS MARTIN

  • Director
5,000 2021-06-10 3

RUFF SHAMIM

  • Director
5,780 2021-06-10 3

OLIGER CHRISTY J.

  • Director
5,180 2021-06-10 3

CASTELLANOS ELAINE VP, CHIEF ACCOUNTING OFFICER

  • Officer
57,414 2021-06-07 5

HUFF JAMES WARREN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
14,083 2021-01-04 3

WORTLEY MICHAEL D CHIEF LEGAL OFFICER

  • Officer
0 2021-01-04 2

BIR DAWN CARTER CHIEF COMMERCIAL OFFICER

  • Officer
0 2021-01-04 2

SONI MANMEET SINGH COO AND CFO

  • Officer
0 2021-01-04 2

CPMG INC

2,896,901 2020-12-23 1

BASS JAMES EDWARD

  • Director
0 2020-06-10 0

WILSON JASON DOUGLAS EXECUTIVE VP OF OPERATIONS

  • Officer
0 2020-01-02 0

TRAWEEK JAMES W JR

3,151,664 2019-12-30 0

ROSE WILLIAM

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

GALE CHARLES E.

CHARLES E. GALE FIDELITY ROLLOVER IRA

ROSE EVELYN P.

EVELYN P. ROSE FIDELITY ROLLOVER IRA

EVELYN POTTER ROSE SURVIVOR'S TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
1,099,583 2019-11-08 1

WARD KEITH WAYNE CHIEF DEVELOPMENT OFFICER

  • Officer
8,620 2019-02-25 0

ROSE WILLIAM

PUFFIN PARTNERS, L.P.

PUFFIN GP, LLC

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

GALE CHARLES E.

CHARLES E. GALE FIDELITY ROLLOVER IRA

ROSE EVELYN P.

EVELYN P. ROSE FIDELITY ROLLOVER IRA

EVELYN POTTER ROSE SURVIVOR'S TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
1,093,305 2018-11-13 1

ROSE WILLIAM

CHARLES HENRY ROSE 2001 TRUST

JOHN WILLIAM ROSE 2002 TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
1,093,305 2018-11-13 1

EVELYN POTTER ROSE SURVIVOR'S TRUST

  • 10% Owner
  • MEMBER OF A 10% OWNER GROUP
879,281 2018-11-13 0

ROSE WILLIAM

PUFFIN PARTNERS, L.P.

PUFFIN GP, LLC

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

GALE CHARLES E.

ESTATE OF EDWARD W. ROSE III

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUP
0 2017-12-07 1

ROSE WILLIAM

PUFFIN PARTNERS, L.P.

PUFFIN GP, LLC

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

GALE CHARLES E.

ESTATE OF EDWARD W. ROSE III

EVELYN POTTER ROSE SURVIVOR'S TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUP
0 2017-12-07 1

NOVO HOLDINGS A/S

  • 10% Owner
0 2017-06-22 0

ABBVIE INC.

  • 10% Owner
No longer subject to file 2017-03-28 0

STONE DENNIS K.

  • Director
0 2016-12-07 0

ROSE WILLIAM

ROSE EVELYN P.

EDWARD W. ROSE FIDELITY ROLLOVER IRA

EVELYN P. ROSE FIDELITY ROLLOVER IRA

GALE CHARLES E.

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP
1,289,744 2016-08-18 0

STAPLETON PHARMA LLC

STAPLETON CRAIG R

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2016-06-09 0

ROSE WILLIAM

ESTATE OF EDWARD W. ROSE III

ROSE EVELYN P.

EDWARD W. ROSE FIDELITY ROLLOVER IRA

GALE CHARLES E.

CHARLES E. GALE FIDELITY ROLLOVER IRA

CHARLES HENRY ROSE 2001 TRUST

JOHN WILLIAM ROSE 2002 TRUST

  • Director
  • 10% Owner
  • MEMBER OF 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUP
1,100,094 2016-06-01 0

PUFFIN PARTNERS, L.P.

PUFFIN GP, LLC

MONTROSE INVESTMENTS I, L.P.

MONTROSE INVESTMENTS GP, LLC

  • 10% Owner
  • MEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUPMEMBER OF A 10% OWNER GROUP
1,100,000 2016-06-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-16 M 19,525 $11.62 a 74,304 direct

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-16 M 19,525 d 0 direct

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-15 S 500 $145.92 d 17,000 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-15 S 8,867 $142.83 d 21,200 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-15 S 4,107 $139.98 d 49,079 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-15 S 1,217 $145.11 d 17,500 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-15 S 12,518 $142.08 d 30,067 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-15 S 3,814 $139.14 d 53,186 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-15 S 2,483 $143.98 d 18,717 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-15 S 6,494 $141.09 d 42,585 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-14 S 12,615 $143.54 d 64,385 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-14 S 2,760 $145.49 d 57,400 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-14 C 5,000 a 77,000 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-14 S 4,225 $144.44 d 60,160 direct -1.3087 0.0 1 -1.3087 2

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-14 C 5,000 d 54,779 direct

MEYER COLIN JOHN - Officer CHIEF RESEARCH OFFICER

2021-06-16 16:04:48 -0400 2021-06-14 S 400 $146.15 d 57,000 direct -1.3087 0.0 1 -1.3087 2

MCGAUGHY R KENT JR - Director - > 10% Owner

2021-06-14 17:25:08 -0400 2021-06-10 A 5,000 a 5,000 direct

EDWARDS MARTIN - Director

2021-06-14 16:11:08 -0400 2021-06-10 A 5,000 a 5,000 direct

OLIGER CHRISTY J. - Director

2021-06-14 11:29:23 -0400 2021-06-10 A 180 $83.24 a 180 direct

NIELSEN JACK - Director

2021-06-14 11:26:03 -0400 2021-06-10 A 5,000 a 5,000 direct

ROSE WILLIAM - Director - > 10% Owner MEMBER OF 10% OWNER GROUP

2021-06-14 16:05:24 -0400 2021-06-10 A 810 $83.24 a 810 direct

RUFF SHAMIM - Director

2021-06-14 11:33:43 -0400 2021-06-10 A 780 $83.24 a 780 direct

OLIGER CHRISTY J. - Director

2021-06-14 11:29:23 -0400 2021-06-10 A 5,000 a 5,000 direct

MCCLELLAN WILLIAM D. JR. - Director

2021-06-14 11:21:46 -0400 2021-06-10 A 5,000 a 5,000 direct

MCGAUGHY R KENT JR - Director - > 10% Owner

2021-06-14 17:25:08 -0400 2021-06-10 A 690 $83.24 a 690 direct

ROSE WILLIAM - Director - > 10% Owner MEMBER OF 10% OWNER GROUP

2021-06-14 16:05:24 -0400 2021-06-10 A 5,000 a 5,000 direct

RUFF SHAMIM - Director

2021-06-14 11:33:43 -0400 2021-06-10 A 5,000 a 5,000 direct

NIELSEN JACK - Director

2021-06-14 11:26:03 -0400 2021-06-10 A 1,201 $83.24 a 1,201 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-09 M 8,454 $22.57 a 8,454 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-09 S 7,900 $141.86 d 15,100 direct -0.0274 -4.2326 0.0 1 -4.2326 6

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-09 M 8,454 d 9,934 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-09 C 8,454 a 23,000 direct -0.0274 -4.2326 0.0 1 -4.2326 6

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-09 C 8,454 d 0 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-09 S 554 $142.50 d 14,546 direct -0.0274 -4.2326 0.0 1 -4.2326 6

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-07 M 1,546 $22.57 a 1,546 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-07 S 910 $146.47 d 15,182 direct -0.0274 -4.2326 0.0 1 -4.2326 6

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-07 M 1,546 d 18,388 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-07 C 1,546 a 16,092 direct -0.0274 -4.2326 0.0 1 -4.2326 6

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-07 C 1,546 d 0 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-06-09 16:28:27 -0400 2021-06-07 S 636 $147.16 d 14,546 direct -0.0274 -4.2326 0.0 1 -4.2326 6

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-05-27 18:15:17 -0400 2021-05-26 C 10,000 a 24,546 direct 1.3822 4.5415 4.5415 6 -0.5777 3

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-05-27 18:15:17 -0400 2021-05-26 M 7,066 $22.57 a 10,000 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-05-27 18:15:17 -0400 2021-05-26 M 2,934 d 0 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-05-27 18:15:17 -0400 2021-05-26 M 2,934 $11.00 a 2,934 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-05-27 18:15:17 -0400 2021-05-26 S 10,000 $124.55 d 14,546 direct 1.3822 4.5415 4.5415 6 -0.5777 3

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-05-27 18:15:17 -0400 2021-05-26 C 10,000 d 0 direct

CASTELLANOS ELAINE - Officer VP, CHIEF ACCOUNTING OFFICER

2021-05-27 18:15:17 -0400 2021-05-26 M 7,066 d 19,934 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
REATA PHARMACEUTICALS INC-A RETA 2021-06-24 14:45:03 UTC -0.1765 0.2565 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-24 14:15:02 UTC -0.1765 0.2565 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-24 13:45:03 UTC -0.1765 0.2565 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-24 13:15:02 UTC -0.1765 0.2565 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-24 12:45:03 UTC -0.1765 0.2565 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 22:15:03 UTC -0.1765 0.2565 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 21:45:03 UTC -0.1765 0.2565 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 21:15:03 UTC -0.1765 0.2565 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 20:45:02 UTC -0.1768 0.2568 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 20:15:04 UTC -0.1768 0.2568 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 19:45:03 UTC -0.1768 0.2568 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 19:15:03 UTC -0.1768 0.2568 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 18:45:02 UTC -0.179 0.259 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 18:15:03 UTC -0.179 0.259 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 17:45:02 UTC -0.179 0.259 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 17:15:03 UTC -0.179 0.259 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 16:45:03 UTC -0.1745 0.2545 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 16:15:03 UTC -0.1745 0.2545 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 15:45:03 UTC -0.1745 0.2545 150000
REATA PHARMACEUTICALS INC-A RETA 2021-06-23 15:15:03 UTC -0.1745 0.2545 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund RETA -4116.0 shares, $-330473.64 2019-09-30 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund RETA -12739.0 shares, $-1022814.31 2019-09-30 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund RETA -23.0 shares, $-3319.82 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund RETA -28.0 shares, $-4041.52 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund RETA -46.0 shares, $-4481.32 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund RETA -36.0 shares, $-5196.24 2020-03-31 N-PORT
ETF Series Solutions- The Acquirers Fund RETA -2059.0 shares, $-213291.81 2021-01-31 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND RETA -1666.0 shares, $-172580.94 2021-01-31 N-PORT
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund RETA -6600.0 shares, $-806916.0 2021-02-28 N-PORT
Nuveen Investment Trust II- Nuveen Equity Long/Short Fund RETA -5300.0 shares, $-647978.0 2021-02-28 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity Fund RETA -262.0 shares, $-32032.12 2021-02-26 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund RETA -551.0 shares, $-54934.7 2021-03-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund RETA -600.0 shares, $-59820.0 2021-03-31 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund RETA -2400.0 shares, $-239280.0 2021-03-31 N-PORT
LoCorr Investment Trust- LoCorr Dynamic Equity Fund RETA -173.0 shares, $-17248.1 2021-03-31 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund RETA -6107.0 shares, $-608867.9 2021-03-31 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio RETA -12000.0 shares, $-1196400.0 2021-03-31 N-PORT
Advanced Series Trust- AST Academic Strategies Asset Allocation Portfolio RETA -2500.0 shares, $-249250.0 2021-03-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund RETA -2734.0 shares, $-272579.8 2021-03-31 N-PORT
AQR Funds- AQR Multi-Asset Fund RETA -1635.0 shares, $-163009.5 2021-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund RETA -13837.0 shares, $-1379548.9 2021-03-31 N-PORT

Elevate your investments